Literature DB >> 23635555

The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.

Soley Bayraktar1, Patricia A Thompson, Suk-Young Yoo, Kim-anh Do, Aysegul A Sahin, Banu K Arun, Melissa L Bondy, Abenaa M Brewster.   

Abstract

BACKGROUND: Several single-nucleotide polymorphisms (SNPs) associated with breast cancer risk have been identified through genome-wide association studies (GWAS). We investigated whether eight risk SNPs identified in GWAS were associated with breast cancer disease-free survival (DFS) and overall survival (OS) rates. PATIENTS AND METHODS: A cohort of 739 white women with early-stage breast cancer was genotyped for eight GWAS-identified SNPs (rs2981582, rs1219648 [FGFR2], rs3803662, rs12443621, rs8051542 [TOX3], rs999737 [RAD51L1], rs6504950 [17q23], and rs4973768 [3p24]). Relationships between SNPs and breast cancer outcomes were evaluated using Cox proportional hazard regression models. The cumulative effects of SNPs on breast cancer outcomes were assessed by computing the number of at-risk genotypes.
RESULTS: At a median follow-up of 121 months (range: 188-231 months) for survivors, 237 deaths (32%) and 186 breast cancer events (25%) were identified among the 739 patients. After adjusting for age, clinical stage, and treatment, rs12443621 (16q12; p = .03) and rs6504950 (17q23; p = .008) were prognostic for OS but not DFS. A higher risk for death was also found in the multivariable analysis of patients harboring three or four at-risk genotypes of the GWAS SNPs compared to patients carrying two or less at-risk genotypes (hazard ratio: 1.60, 95% confidence interval: 1.23-2.24; p = .0008).
CONCLUSION: The study results suggest that previously identified breast cancer risk susceptibility loci, rs12443621 (16q12) and rs6504950 (17q23), may influence breast cancer prognosis or comorbid conditions associated with overall survival. The precise molecular mechanisms through which these risk SNPs, as well as others that were not included in the analysis, influence clinical outcomes remain to be determined.

Entities:  

Keywords:  17q23; Breast cancer; Prognosis; Single-nucleotide polymorphisms; TNRC9

Mesh:

Year:  2013        PMID: 23635555      PMCID: PMC3662839          DOI: 10.1634/theoncologist.2012-0419

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  51 in total

1.  Genes associated with breast cancer metastatic to bone.

Authors:  Marcel Smid; Yixin Wang; Jan G M Klijn; Anieta M Sieuwerts; Yi Zhang; David Atkins; John W M Martens; John A Foekens
Journal:  J Clin Oncol       Date:  2006-04-24       Impact factor: 44.544

Review 2.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

3.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.

Authors:  Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy Garber; Eitan Friedman; Steven Narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan A Ellis; Robert J Klein; Andrew G Clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-07       Impact factor: 11.205

4.  Novel genetic markers of breast cancer survival identified by a genome-wide association study.

Authors:  Xiao Ou Shu; Jirong Long; Wei Lu; Chun Li; Wendy Y Chen; Ryan Delahanty; Jiarong Cheng; Hui Cai; Ying Zheng; Jiajun Shi; Kai Gu; Wen-Jing Wang; Peter Kraft; Yu-Tang Gao; Qiuyin Cai; Wei Zheng
Journal:  Cancer Res       Date:  2012-01-09       Impact factor: 12.701

5.  Transcriptional consequences of genomic structural aberrations in breast cancer.

Authors:  Koichiro Inaki; Axel M Hillmer; Leena Ukil; Fei Yao; Xing Yi Woo; Leah A Vardy; Kelson Folkvard Braaten Zawack; Charlie Wah Heng Lee; Pramila Nuwantha Ariyaratne; Yang Sun Chan; Kartiki Vasant Desai; Jonas Bergh; Per Hall; Thomas Choudary Putti; Wai Loon Ong; Atif Shahab; Valere Cacheux-Rataboul; Radha Krishna Murthy Karuturi; Wing-Kin Sung; Xiaoan Ruan; Guillaume Bourque; Yijun Ruan; Edison T Liu
Journal:  Genome Res       Date:  2011-04-05       Impact factor: 9.043

6.  Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

Authors:  Wei Zheng; Jirong Long; Yu-Tang Gao; Chun Li; Ying Zheng; Yong-Bin Xiang; Wanqing Wen; Shawn Levy; Sandra L Deming; Jonathan L Haines; Kai Gu; Alecia Malin Fair; Qiuyin Cai; Wei Lu; Xiao-Ou Shu
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

7.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.

Authors:  Simon N Stacey; Andrei Manolescu; Patrick Sulem; Steinunn Thorlacius; Sigurjon A Gudjonsson; Gudbjörn F Jonsson; Margret Jakobsdottir; Jon T Bergthorsson; Julius Gudmundsson; Katja K Aben; Luc J Strobbe; Dorine W Swinkels; K C Anton van Engelenburg; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Esther Millastre; Raquel Andres; Berta Saez; Julio Lambea; Javier Godino; Eduardo Polo; Alejandro Tres; Simone Picelli; Johanna Rantala; Sara Margolin; Thorvaldur Jonsson; Helgi Sigurdsson; Thora Jonsdottir; Jon Hrafnkelsson; Jakob Johannsson; Thorarinn Sveinsson; Gardar Myrdal; Hlynur Niels Grimsson; Steinunn G Sveinsdottir; Kristin Alexiusdottir; Jona Saemundsdottir; Asgeir Sigurdsson; Jelena Kostic; Larus Gudmundsson; Kristleifur Kristjansson; Gisli Masson; James D Fackenthal; Clement Adebamowo; Temidayo Ogundiran; Olufunmilayo I Olopade; Christopher A Haiman; Annika Lindblom; Jose I Mayordomo; Lambertus A Kiemeney; Jeffrey R Gulcher; Thorunn Rafnar; Unnur Thorsteinsdottir; Oskar T Johannsson; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

8.  A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma.

Authors:  Ramon Colomer; Mariano Monzo; Ignasi Tusquets; Juli Rifa; José M Baena; Agusti Barnadas; Lourdes Calvo; Francisco Carabantes; Carmen Crespo; Montserrat Muñoz; Antonio Llombart; Arrate Plazaola; Rosa Artells; Monstsrrat Gilabert; Belen Lloveras; Emilio Alba
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

9.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

Authors:  Shahana Ahmed; Gilles Thomas; Maya Ghoussaini; Catherine S Healey; Manjeet K Humphreys; Radka Platte; Jonathan Morrison; Melanie Maranian; Karen A Pooley; Robert Luben; Diana Eccles; D Gareth Evans; Olivia Fletcher; Nichola Johnson; Isabel dos Santos Silva; Julian Peto; Michael R Stratton; Nazneen Rahman; Kevin Jacobs; Ross Prentice; Garnet L Anderson; Aleksandar Rajkovic; J David Curb; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; W Ryan Diver; Stig Bojesen; Børge G Nordestgaard; Henrik Flyger; Thilo Dörk; Peter Schürmann; Peter Hillemanns; Johann H Karstens; Natalia V Bogdanova; Natalia N Antonenkova; Iosif V Zalutsky; Marina Bermisheva; Sardana Fedorova; Elza Khusnutdinova; Daehee Kang; Keun-Young Yoo; Dong Young Noh; Sei-Hyun Ahn; Peter Devilee; Christi J van Asperen; R A E M Tollenaar; Caroline Seynaeve; Montserrat Garcia-Closas; Jolanta Lissowska; Louise Brinton; Beata Peplonska; Heli Nevanlinna; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; John L Hopper; Melissa C Southey; Letitia Smith; Amanda B Spurdle; Marjanka K Schmidt; Annegien Broeks; Richard R van Hien; Sten Cornelissen; Roger L Milne; Gloria Ribas; Anna González-Neira; Javier Benitez; Rita K Schmutzler; Barbara Burwinkel; Claus R Bartram; Alfons Meindl; Hiltrud Brauch; Christina Justenhoven; Ute Hamann; Jenny Chang-Claude; Rebecca Hein; Shan Wang-Gohrke; Annika Lindblom; Sara Margolin; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Janet E Olson; Xianshu Wang; Zachary Fredericksen; Graham G Giles; Gianluca Severi; Laura Baglietto; Dallas R English; Susan E Hankinson; David G Cox; Peter Kraft; Lars J Vatten; Kristian Hveem; Merethe Kumle; Alice Sigurdson; Michele Doody; Parveen Bhatti; Bruce H Alexander; Maartje J Hooning; Ans M W van den Ouweland; Rogier A Oldenburg; Mieke Schutte; Per Hall; Kamila Czene; Jianjun Liu; Yuqing Li; Angela Cox; Graeme Elliott; Ian Brock; Malcolm W R Reed; Chen-Yang Shen; Jyh-Cherng Yu; Giu-Cheng Hsu; Shou-Tung Chen; Hoda Anton-Culver; Argyrios Ziogas; Irene L Andrulis; Julia A Knight; Jonathan Beesley; Ellen L Goode; Fergus Couch; Georgia Chenevix-Trench; Robert N Hoover; Bruce A J Ponder; David J Hunter; Paul D P Pharoah; Alison M Dunning; Stephen J Chanock; Douglas F Easton
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

10.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

View more
  15 in total

Review 1.  TOX gene: a novel target for human cancer gene therapy.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

2.  Common germline polymorphisms associated with breast cancer-specific survival.

Authors:  Ailith Pirie; Qi Guo; Peter Kraft; Sander Canisius; Diana M Eccles; Nazneen Rahman; Heli Nevanlinna; Constance Chen; Sofia Khan; Jonathan Tyrer; Manjeet K Bolla; Qin Wang; Joe Dennis; Kyriaki Michailidou; Michael Lush; Alison M Dunning; Mitul Shah; Kamila Czene; Hatef Darabi; Mikael Eriksson; Dieter Lambrechts; Caroline Weltens; Karin Leunen; Chantal van Ongeval; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Carl Blomqvist; Kristiina Aittomäki; Rainer Fagerholm; Taru A Muranen; Janet E Olsen; Emily Hallberg; Celine Vachon; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Annegien Broeks; Sten Cornelissen; Christopher A Haiman; Brian E Henderson; Frederick Schumacher; Loic Le Marchand; John L Hopper; Helen Tsimiklis; Carmel Apicella; Melissa C Southey; Simon S Cross; Malcolm Wr Reed; Graham G Giles; Roger L Milne; Catriona McLean; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Maartje J Hooning; Antoinette Hollestelle; John Wm Martens; Ans Mw van den Ouweland; Federick Marme; Andreas Schneeweiss; Rongxi Yang; Barbara Burwinkel; Jonine Figueroa; Stephen J Chanock; Jolanta Lissowska; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Hermann Brenner; Katja Butterbach; Bernd Holleczek; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Jingmei Li; Judith S Brand; Keith Humphreys; Peter Devilee; Robert Aem Tollenaar; Caroline Seynaeve; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Filomena Ficarazzi; Matthias W Beckmann; Alexander Hein; Arif B Ekici; Rosemary Balleine; Kelly-Anne Phillips; Javier Benitez; M Pilar Zamora; Jose Ignacio Arias Perez; Primitiva Menéndez; Anna Jakubowska; Jan Lubinski; Jacek Gronwald; Katarzyna Durda; Ute Hamann; Maria Kabisch; Hans Ulrich Ulmer; Thomas Rüdiger; Sara Margolin; Vessela Kristensen; Siljie Nord; D Gareth Evans; Jean Abraham; Helena Earl; Christopher J Poole; Louise Hiller; Janet A Dunn; Sarah Bowden; Rose Yang; Daniele Campa; W Ryan Diver; Susan M Gapstur; Mia M Gaudet; Susan Hankinson; Robert N Hoover; Anika Hüsing; Rudolf Kaaks; Mitchell J Machiela; Walter Willett; Myrto Barrdahl; Federico Canzian; Suet-Feung Chin; Carlos Caldas; David J Hunter; Sara Lindstrom; Montserrat Garcia-Closas; Fergus J Couch; Georgia Chenevix-Trench; Arto Mannermaa; Irene L Andrulis; Per Hall; Jenny Chang-Claude; Douglas F Easton; Stig E Bojesen; Angela Cox; Peter A Fasching; Paul Dp Pharoah; Marjanka K Schmidt
Journal:  Breast Cancer Res       Date:  2015-04-22       Impact factor: 6.466

3.  TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.

Authors:  Ying Chen; Chunying Shi; Qiyong Guo
Journal:  World J Surg Oncol       Date:  2016-02-24       Impact factor: 2.754

4.  Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.

Authors:  Dong Gui Hu; Ross A McKinnon; Julie-Ann Hulin; Peter I Mackenzie; Robyn Meech
Journal:  Int J Mol Sci       Date:  2016-12-27       Impact factor: 5.923

5.  Association of FGFR2 rs2981582, SIRT1 rs12778366, STAT3 rs744166 gene polymorphisms with pituitary adenoma.

Authors:  Brigita Glebauskiene; Alvita Vilkeviciute; Rasa Liutkeviciene; Silvija Jakstiene; Loresa Kriauciuniene; Reda Zemaitiene; Dalia Zaliuniene
Journal:  Oncol Lett       Date:  2017-03-10       Impact factor: 2.967

6.  The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.

Authors:  Chaowen Jiang; Shilong Yu; Pin Qian; Ruiling Guo; Ruijie Zhang; Zhi Ao; Qi Li; Guoming Wu; Yan Chen; Jin Li; Changzheng Wang; Wei Yao; Jiancheng Xu; Guisheng Qian; Fuyun Ji
Journal:  Oncotarget       Date:  2016-09-13

7.  Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.

Authors:  Sung-Hsin Kuo; Shi-Yi Yang; San-Lin You; Huang-Chun Lien; Ching-Hung Lin; Po-Han Lin; Chiun-Sheng Huang
Journal:  Oncotarget       Date:  2017-03-28

8.  Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.

Authors:  Elsa Curtit; Xavier Pivot; Julie Henriques; Sophie Paget-Bailly; Pierre Fumoleau; Maria Rios; Hervé Bonnefoi; Thomas Bachelot; Patrick Soulié; Christelle Jouannaud; Hugues Bourgeois; Thierry Petit; Isabelle Tennevet; David Assouline; Marie-Christine Mathieu; Jean-Philippe Jacquin; Sandrine Lavau-Denes; Ariane Darut-Jouve; Jean-Marc Ferrero; Carole Tarpin; Christelle Lévy; Valérie Delecroix; Véronique Trillet-Lenoir; Oana Cojocarasu; Jérôme Meunier; Jean-Yves Pierga; Pierre Kerbrat; Céline Faure-Mercier; Hélène Blanché; Mourad Sahbatou; Anne Boland; Delphine Bacq; Céline Besse; Gilles Thomas; Jean-François Deleuze; Iris Pauporté; Gilles Romieu; David G Cox
Journal:  Breast Cancer Res       Date:  2017-08-22       Impact factor: 6.466

9.  CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer.

Authors:  Sung-Hsin Kuo; Shi-Yi Yang; Huang-Chun Lien; Chiao Lo; Ching-Hung Lin; Yen-Sen Lu; Ann-Lii Cheng; King-Jeng Chang; Chiun-Sheng Huang
Journal:  Biomed Res Int       Date:  2013-11-14       Impact factor: 3.411

10.  Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer.

Authors:  Fangmeng Fu; Wenhui Guo; Yuxiang Lin; Bangwei Zeng; Wei Qiu; Meng Huang; Chuan Wang
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.